The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone

This study has been terminated.
(Study was terminated due to patient complications unrelated to study drugs)
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by (Responsible Party):
Jill Bashutski, University of Michigan
ClinicalTrials.gov Identifier:
NCT01279187
First received: January 18, 2011
Last updated: April 20, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2015
  Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)